These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol]. Choi SH, Yang SH, Song YB, Kim HJ, Seo YT, Choi DS, Moon KH, Byun JH, Yu ES. Korean J Hepatol; 2005 Mar 16; 11(1):80-5. PubMed ID: 15788888 [Abstract] [Full Text] [Related]
6. Fatal allopurinol-induced hypersensitivity syndrome associated with pancreatic abnormalities. Fathallah N, Ben Salem C, Slim R, Kaabia N, Letaief A, Bouraoui K. J Clin Rheumatol; 2010 Jun 16; 16(4):170-1. PubMed ID: 20511977 [Abstract] [Full Text] [Related]
7. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, Dalbeth N. Arthritis Rheum; 2012 Aug 16; 64(8):2529-36. PubMed ID: 22488501 [Abstract] [Full Text] [Related]
9. A review of inpatients with adverse drug reactions to allopurinol. Khoo BP, Leow YH. Singapore Med J; 2000 Apr 16; 41(4):156-60. PubMed ID: 11063179 [Abstract] [Full Text] [Related]
11. The allopurinol hypersensitivity syndrome. Pluim HJ, van Deuren M, Wetzels JF. Neth J Med; 1998 Mar 16; 52(3):107-10. PubMed ID: 9599967 [Abstract] [Full Text] [Related]
12. Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction? Lee HY, Ariyasinghe JT, Thirumoorthy T. Singapore Med J; 2008 May 16; 49(5):384-7. PubMed ID: 18465047 [Abstract] [Full Text] [Related]
14. [Side effects off allopurinol]. Rødevand E, Sletvold O, Kvande KT. Tidsskr Nor Laegeforen; 2004 Oct 21; 124(20):2618-9. PubMed ID: 15534635 [Abstract] [Full Text] [Related]
19. [Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome]. Hammer B, Link A, Wagner A, Böhm M. Dtsch Med Wochenschr; 2001 Nov 23; 126(47):1331-4. PubMed ID: 11719858 [Abstract] [Full Text] [Related]
20. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events. Dalbeth N, Stamp L. Semin Dial; 2007 Nov 23; 20(5):391-5. PubMed ID: 17897242 [Abstract] [Full Text] [Related] Page: [Next] [New Search]